Zenith Health Care (BSE 530665)₹3.25+2.85%Pharmaceuticals
In the Mar 2026 quarter (standalone), Zenith Health Care reported sales of ₹2.61 Cr, down 23.7% from Mar 2025, and net profit of −₹0.33 Cr, down 430.0% year on year. For the year to Mar 2026, sales were ₹10.49 Cr and net profit ₹0 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.06 | 3.48 | 3.88 | 3.06 | 2.56 | 3.02 | 2.30 | 3.42 | 3.14 | 2.26 | 2.47 | 2.61 |
| Expenses | 3.77 | 3.37 | 3.80 | 3.32 | 2.46 | 2.90 | 2.52 | 3.42 | 3.30 | 2.11 | 2.21 | 3.09 |
| Operating Profit | 0.32 | 0.14 | 0.11 | −0.25 | 0.13 | 0.15 | −0.21 | 0.03 | −0.15 | 0.18 | 0.29 | −0.47 |
| OPM % | 7.6% | 3.7% | 2.6% | −7.9% | 4.6% | 4.6% | −8.7% | 0.6% | −4.5% | 7.5% | 11.2% | −17.7% |
| Other Income | 0.00 | 0.05 | 0.07 | 0.12 | 0.09 | 0.09 | 0.17 | 0.12 | 0.18 | 0.12 | 0.05 | 0.11 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.06 | 0.05 | 0.06 | 0.04 | 0.05 | 0.05 | 0.08 | 0.09 | 0.07 | 0.08 | 0.06 | 0.05 |
| Profit before tax | 0.25 | 0.10 | 0.09 | −0.17 | 0.15 | 0.17 | −0.10 | 0.04 | −0.02 | 0.20 | 0.24 | −0.41 |
| Tax % | 0.0% | 0.0% | 0.0% | 38.9% | 0.0% | 44.4% | 172.7% | −120.0% | −33.3% | 38.1% | 8.0% | −19.1% |
| Net Profit | 0.25 | 0.11 | 0.09 | −0.25 | 0.15 | 0.08 | −0.28 | 0.10 | −0.01 | 0.13 | 0.21 | −0.33 |
| EPS (Rs) | 0.04 | 0.01 | 0.01 | −0.04 | 0.02 | 0.01 | −0.04 | 0.01 | 0.00 | 0.02 | 0.03 | −0.05 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.45 | 4.78 | 9.49 | 9.81 | 11.95 | 13.70 | 22.29 | 13.10 | 14.44 | 11.30 | 10.49 | 10.48 |
| Expenses | 3.70 | 4.74 | 8.97 | 9.65 | 11.46 | 13.40 | 21.96 | 13.13 | 14.26 | 11.26 | 10.67 | 10.71 |
| Operating Profit | −0.24 | 0.07 | 0.57 | 0.21 | 0.56 | 0.37 | 0.46 | 0.04 | 0.25 | 0.10 | −0.14 | −0.15 |
| OPM % | −6.7% | 1.2% | 5.9% | 2.0% | 4.6% | 2.6% | 2.0% | 0.2% | 1.7% | 0.8% | −1.3% | −1.4% |
| Other Income | 0.13 | 0.07 | 0.14 | 0.22 | 0.31 | 0.47 | 0.51 | 0.39 | 0.27 | 0.44 | 0.42 | 0.46 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.34 | 0.31 | 0.27 | 0.24 | 0.26 | 0.24 | 0.35 | 0.27 | 0.20 | 0.24 | 0.25 | 0.26 |
| Profit before tax | −0.46 | −0.16 | 0.39 | 0.15 | 0.58 | 0.55 | 0.59 | 0.11 | 0.27 | 0.27 | 0.00 | 0.01 |
| Tax % | −36.2% | −11.8% | 32.5% | 18.7% | 3.4% | 19.6% | 48.3% | 33.3% | 25.0% | 78.6% | 200.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −0.30 | −0.14 | 0.26 | 0.13 | 0.56 | 0.43 | 0.30 | 0.07 | 0.19 | 0.06 | 0.00 | 0.00 |
| EPS (Rs) | −0.05 | −0.02 | 0.04 | 0.02 | 0.10 | 0.07 | 0.05 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.38 | 5.38 | 5.39 | 5.39 | 5.39 | 5.39 | 5.39 | 5.38 | 5.38 | 5.38 | 5.38 | 5.38 |
| Reserves | 0.47 | 0.16 | 0.01 | 0.28 | 0.43 | 1.03 | 1.46 | 1.77 | 1.85 | 1.95 | 2.02 | 2.04 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.60 | 1.04 | 0.75 | 1.42 | 1.14 | 2.15 | 1.91 | 4.52 | 2.02 | 2.56 | 3.48 | 3.58 |
| Total Liabilities | 6.45 | 6.58 | 6.15 | 7.09 | 6.98 | 8.57 | 8.76 | 11.67 | 9.25 | 9.89 | 10.88 | 11.00 |
| Fixed Assets | 2.18 | 1.94 | 1.76 | 1.82 | 1.63 | 1.71 | 1.81 | 1.76 | 1.51 | 1.41 | 1.56 | 1.46 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 4.27 | 4.64 | 4.39 | 5.27 | 5.35 | 6.68 | 6.95 | 9.91 | 7.74 | 8.48 | 9.32 | 9.54 |
| Inventories | 1.02 | 1.53 | 1.38 | 1.52 | 2.29 | 1.99 | 3.25 | 3.61 | 3.25 | 1.97 | 2.26 | 2.91 |
| Trade receivables | 1.82 | 1.25 | 1.10 | 1.42 | 0.90 | 1.01 | 1.68 | 3.24 | 2.30 | 2.26 | 2.41 | 2.08 |
| Cash & equivalents | 0.48 | 0.72 | 0.83 | 1.08 | 0.99 | 2.42 | 0.77 | 1.86 | 0.91 | 2.54 | 2.73 | 0.36 |
| Total Assets | 6.45 | 6.58 | 6.15 | 7.09 | 6.98 | 8.57 | 8.76 | 11.67 | 9.25 | 9.89 | 10.88 | 11.00 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.20 | 0.24 | 0.24 | −0.07 | 1.96 | −1.48 | 1.33 | −0.93 | 1.75 | 0.68 | −0.84 |
| Cash from investing activity | −0.13 | 0.02 | −0.11 | −0.04 | −0.51 | −0.18 | −0.22 | −0.04 | −1.89 | −1.10 | 0.84 |
| Cash from financing activity | 0.00 | 0.00 | 0.00 | 0.03 | −0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.02 |
| Net cash flow | 0.06 | 0.23 | 0.12 | −0.08 | 1.45 | −1.64 | 1.08 | −0.94 | −0.13 | −0.40 | 0.02 |
| Capex | 0.38 | 0.13 | 0.13 | 0.06 | 0.51 | 0.20 | 0.25 | 0.04 | 0.12 | 0.40 | 0.17 |
| Free cash flow | −0.19 | 0.12 | 0.12 | −0.12 | 1.46 | −1.67 | 1.09 | −0.96 | 1.64 | 0.29 | −1.00 |
| CFO / OP % | −475.0% | −100.0% | 383.0% | −15.0% | 356.0% | −372.0% | 333.0% | −2,967.0% | 796.0% | 800.0% | 615.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 182 | 132 | 84 | 54 | 33 | 30 | 44 | 52 | 63 | 56 | 77 | 72 |
| Inventory days | 170 | 296 | 179 | 102 | 125 | 98 | 144 | 104 | 146 | 86 | 152 | 219 |
| Days payable | 87 | 179 | 80 | 84 | 49 | 85 | 72 | 39 | 52 | 39 | 93 | 114 |
| Cash conversion cycle | 268 | 253 | 186 | 75 | 112 | 46 | 119 | 120 | 161 | 106 | 139 | 179 |
| Working capital days | 248 | 210 | 137 | 83 | 97 | 49 | 99 | 52 | 118 | 62 | 71 | 123 |
| ROCE % | −5.7% | −8.1% | −3.0% | 7.4% | 2.8% | 9.8% | 8.6% | 8.7% | 1.8% | 4.0% | 3.1% | 0.3% |
For the Mar 2026 quarter, Zenith Health Care reported sales of ₹2.61 Cr, down 23.7% year on year and net profit of −₹0.33 Cr, down 430.0% year on year. The operating margin was −17.7%.
Zenith Health Care's sales for the year to Mar 2026 were ₹10.49 Cr; over the last twelve months they were ₹10.48 Cr.
Net profit for the year to Mar 2026 was ₹0 Cr, and ₹0 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.00.
Zenith Health Care reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0.36 Cr.
Cash from operations was −₹0.84 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹1 Cr.